The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125627481 12562748 1 I 20160504 20160706 20160715 20160715 EXP GB-MHRA-ADR23549509 GB-009507513-1607GBR004921 MERCK 48.00 YR M Y 0.00000 20160715 CN IE GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125627481 12562748 1 PS DEXAMETHASONE. DEXAMETHASONE 1 Oral 20 MG, ON DAYS 1, 2,4,5,8,9,11 AND 12 Y 12675 20 MG TABLET
125627481 12562748 2 SS DEXAMETHASONE. DEXAMETHASONE 1 Oral 20 MG, UNKNOWN Y 12675 20 MG TABLET
125627481 12562748 3 SS DEXAMETHASONE. DEXAMETHASONE 1 Oral 20 MG, UNKNOWN Y 12675 20 MG TABLET
125627481 12562748 4 SS VELCADE BORTEZOMIB 1 Subcutaneous 1.3 MG/M2 2 IN 1 WK, ON DAYS 1,4,8 AND 11 CYCLE 1, BIW 0 1.3 MG/M**2 POWDER BIW
125627481 12562748 5 SS VELCADE BORTEZOMIB 1 Subcutaneous 1 MG/M2 2 IN 1 WK, ON DAYS 1,4,8 AND 11 CYCLE 1 BIW 0 1 MG/M**2 POWDER BIW
125627481 12562748 6 SS VELCADE BORTEZOMIB 1 Subcutaneous 1 MG/M2 2 IN 1 WK, ON DAYS 1,4,8 AND 11 CYCLE 1, BIW 0 1 MG/M**2 POWDER BIW
125627481 12562748 7 C ACYCLOVIR. ACYCLOVIR 1 Oral 800 MG, 2 IN 1 D U 0 800 MG BID
125627481 12562748 8 C ALLOPURINOL. ALLOPURINOL 1 Oral 300 MG, 1 IN 1 M U 0 300 MG /month
125627481 12562748 9 C AMITRIPTYLINE HYDROCHLORIDE. AMITRIPTYLINE HYDROCHLORIDE 1 Oral 1 DF, 1 IN 1 D U 0 1 DF TABLET QD
125627481 12562748 10 C ACETAMINOPHEN. ACETAMINOPHEN 1 Oral 4 G, 4 IN 1 D U 0 4 G QID
125627481 12562748 11 C TRAMADOL HYDROCHLORIDE. TRAMADOL HYDROCHLORIDE 1 Oral 150 MG, 3 IN 1 D U 0 150 MG TID
125627481 12562748 12 C CODEINE CODEINE 1 Oral 1 DF, 1 AS REQUIRED U 0
125627481 12562748 13 C ZOPICLONE ZOPICLONE 1 Oral AT NIGHT, 1 IN 1 D U 0 1 DF QD
125627481 12562748 14 C OMEPRAZOLE. OMEPRAZOLE 1 Oral 20 MG, 1 IN 1 D U 0 20 MG CAPSULE QD
125627481 12562748 15 C LAXIDO POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE 1 Oral 1 AS REQUIRED U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125627481 12562748 1 Plasma cell myeloma
125627481 12562748 4 Plasma cell myeloma
125627481 12562748 7 Antiviral prophylaxis
125627481 12562748 8 Prophylaxis
125627481 12562748 10 Back pain
125627481 12562748 11 Back pain
125627481 12562748 12 Back pain
125627481 12562748 13 Insomnia
125627481 12562748 14 Gastrointestinal disorder therapy
125627481 12562748 15 Constipation

Outcome of event

Event ID CASEID OUTC COD
125627481 12562748 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125627481 12562748 Pyrexia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125627481 12562748 1 20151214 0
125627481 12562748 2 20160418 20160509 0
125627481 12562748 3 20160516 0
125627481 12562748 4 20151214 0
125627481 12562748 5 20160418 20160509 0
125627481 12562748 6 20160516 0
125627481 12562748 7 20151214 0
125627481 12562748 8 20151214 0
125627481 12562748 9 20151221 0
125627481 12562748 12 2015 0
125627481 12562748 14 20151214 0
125627481 12562748 15 2015 0